TY - JOUR
T1 - Practice parameters for the treatment of narcolepsy
T2 - An update for 2000
AU - Littner, M.
AU - Johnson, S. F.
AU - McCall, William Vaughn
AU - Anderson, W. McDowell
AU - Davila, D.
AU - Hartse, K.
AU - Kushida, C. A.
AU - Wise, M. S.
AU - Hirshkowitz, M.
AU - Woodson, B. T.
PY - 2001/6/15
Y1 - 2001/6/15
N2 - Successful treatment of narcolepsy requires an accurate diagnosis to exclude patients with other sleep disorders, which have different treatments, and to avoid unnecessary complications of drug treatment. Treatment objectives should be tailored to individual circumstances. Modafinil, amphetamine, methamphetamine, dextroamphetamine, methylphenidate, selegiline, pemoline, tricyclic antidepressants, and fluoxetine are effective treatments for narcolepsy, but the quality of published clinical evidence supporting them varies. Scheduled naps can be beneficial to combat sleepiness, but naps seldom suffice as primary therapy. Regular follow up of patients with narcolepsy is necessary to educate patients and their families, monitor for complications of therapy and emergent of other sleep disorders, and help the patient adapt to the disease.
AB - Successful treatment of narcolepsy requires an accurate diagnosis to exclude patients with other sleep disorders, which have different treatments, and to avoid unnecessary complications of drug treatment. Treatment objectives should be tailored to individual circumstances. Modafinil, amphetamine, methamphetamine, dextroamphetamine, methylphenidate, selegiline, pemoline, tricyclic antidepressants, and fluoxetine are effective treatments for narcolepsy, but the quality of published clinical evidence supporting them varies. Scheduled naps can be beneficial to combat sleepiness, but naps seldom suffice as primary therapy. Regular follow up of patients with narcolepsy is necessary to educate patients and their families, monitor for complications of therapy and emergent of other sleep disorders, and help the patient adapt to the disease.
UR - https://augusta.pure.elsevier.com/en/publications/556b1d30-6df4-4292-a9d9-7f3a3b6ea946
M3 - Article
C2 - 11403530
SN - 0161-8105
JO - Sleep
JF - Sleep
ER -